Evidence map›Paper›PMID 40872952›Full record

ArticleVaccines2025

Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination.

Heiko Pfister, Carsten Uhlig, Zsuzsanna Mayer, Eleni Polatoglou, Hannah Randeu, Silke Burglechner-Praun, Tabea Berchtold, Susanne Sernetz, Felicitas Heitzer, Andrea Strötges-Achatz and 3 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Heiko PfisterMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Carsten UhligMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Zsuzsanna MayerMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Eleni PolatoglouMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Hannah RandeuMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Silke Burglechner-PraunMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Tabea BerchtoldMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Susanne SernetzOccupational Medicine Service, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Felicitas HeitzerOccupational Medicine Service, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Andrea Strötges-AchatzOccupational Medicine Service, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Ludwig DemlMikrogen GmbH, Anna-Sigmund-Str. 10, 82061 Neuried, Germany.
Michaela SanderMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.
Stefan HoldenriederMunich Biomarker Research Center, Institute of Laboratory Medicine, TUM University Hospital German Heart Center, Lazarettstr. 36, 80636 Munich, Germany.ORCID 0000-0001-9210-7064

Funding

Roche Diagnostics (Germany)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adaptive immunityantibodiescellular immune responsemRNA vaccineOmicronpredictive markersSARS-CoV-2vaccinationviral infection

Identifiers

PMID40872952
PMCPMC12390141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.